Avoiding, Treating & Curing Cancer With the Immune System | Dr. Alex Marson

Name: Avoiding, Treating & Curing Cancer With the Immune System | Dr. Alex Marson
Uploaded: 2026-03-09T12:01:37Z
Channel: Andrew Huberman

March 09, 2026

Andrew Huberman host

Watch on YouTube cancer immunotherapy car t-cell therapy crispr gene editing immune system function cancer prevention precision medicine t cells

Huberman interviews Dr. Alex Marson about how the immune system can be reprogrammed to fight cancer through CAR T-cell therapy and CRISPR gene editing. The discussion covers cancer prevention, the mechanisms of cancer development, breakthrough immunotherapy treatments, and cutting-edge genetic technologies that are transitioning from science fiction to clinical reality. Marson explains how immune cells can be engineered to precisely target and destroy cancer cells while sparing healthy tissue.

Key takeaways

• Smoking, UV exposure, and pesticides are the most significant modifiable cancer risk factors, though many people get cancer despite doing everything right and cannot be blamed for their diagnosis.
• CAR T-cell therapy (chimeric antigen receptor T cells) represents a paradigm shift where a patient's own immune cells are genetically modified to recognize and destroy cancer, with dramatic success in childhood leukemias and some adult cancers.
• CRISPR gene editing emerged in 2012 as a revolutionary tool that allows scientists to cut DNA at precisely targeted locations with RNA guidance, enabling far more precise and programmable cellular modifications than previous technologies.
• The immune system's balance between fighting infections and avoiding autoimmunity is delicate; early-life exposure to pathogens and allergens appears critical for building tolerance, and antibiotics for bacterial infections do not weaken the immune system.
• Checkpoint inhibitor drugs like PD-1 and CTLA-4 inhibitors work by removing natural "brakes" on T cells, allowing the immune system to attack cancer; these have been remarkably successful in melanoma and other cancers.
• Newer CRISPR variants like base editors and epigenetic editors avoid cutting DNA entirely, instead making more controlled, predictable changes or turning genes on/off without altering the DNA sequence itself, reducing unintended consequences.